Thalidomide causes platelet activation, which can be abrogated by aspirin
Authors:
- 1 June 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (6) , 1323-1325
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effects of Aspirin on Intra-Platelet Vascular Endothelial Growth Factor, Angiopoietin-1, and P-Selectin Levels in Hypertensive PatientsAmerican Journal of Hypertension, 2006
- Nuclear Factor-κB-Independent Anti-Inflammatory Action of Salicylate in Human Endothelial Cells: Induction of Heme Oxygenase-1 by the c-Jun N-Terminal Kinase/Activator Protein-1 PathwayThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomideJournal of Thrombosis and Haemostasis, 2006
- Thalidomide Therapy and Deep Venous Thrombosis in Multiple MyelomaMayo Clinic Proceedings, 2005
- The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple MyelomaMayo Clinic Proceedings, 2005
- Markers of endothelial and haemostatic function in the treatment of relapsed myeloma with the immunomodulatory agent ActimidTM (CC‐4047) and their relationship with venous thrombosisEuropean Journal of Haematology, 2005
- Platelet activation can occur by shear stress alone in the PFA-100 platelet analyserPlatelets, 2005
- Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulationBritish Journal of Haematology, 2004